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    The subject’s 6f these’studies were 240 patients ’with primary bladder tumors， who were treated
in the Urological Department of Mie Un三versity Hospital and o£Shiohama Hospital du血g 10 years
from Jan． 1965 to Dec． 1974． Of these’ cases， the incidence rate， cystoscopic findings， histologic find－
ings， therapy of follow－up studies are reported as follows．
    1） lncidence
    Two hundred 4nd forty patients with bladder tumors were 1．10 per cent of the total number
of out－patients treated at the above hospitals， the ratio between male and female patients was 4：1．．
About ninety－five per cent of patients with bladder tumors were over forty years of age． The highest
perceritage of affected patients （32．9％） was in their sixties followed by those in their seventies， fifties，
and forties．
    2） Cystoscopic findings
    The sites of the neoplastic growths mostly originated on the lateral wall of the bladder and less
so on the trigone and the posterior wall and there were even fewer cases on the bladder neck， the dome
area of the anterior wall． Most of tumors （61．3％） showed single growths compared with multiple
gtowths （38，790i）． The tumors were from rice grain to walnut in size and had various shapes． Of
all the cases s．tudied there Were 93 papillary and pedunculated cases （54・．7％）， 39 papillary and sessile
cases （22．4％） and 38 non－papillary and sessile cases．
    ．3）Histologic丘ndings
    Of 159 cases histologically examined， 151 cases （95．1％） were transitional cell carcinoma， the
the grading of which was as follows： 17 cases Grade 1 （11．3％）， 74 cases Grade It （49．0％）， 47 cases
Grade III （31．1％） and 13 cases Grade IV （8．6％）， respectively． The number of patients with
squamous cell carcinoma was 4 （2．5％） and with adenocarcinoma 3 （1．9％）， including 2 with urachal
adenQcarcinoma． Concerning non－epithelial tumors， a case of leiomyosarcoma （O．6ftOo一） was noted．
There was no evidence of any relationship between the grading of the tumors and the chief complaints
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of the patients． Most of the small or tiny growths were histologically characterized by well differen－
tiated transitonal cell carcinoma （Grade 1 or II）， while medium or large sized tumors showed low
differentiation in appearance （Grade III or IV）． The papillary and sessile tumors were largely
characterized by well－differentiated transitional cell carcinoma， compared with the non－papillary
tumors showing mostly lower differentiation in histological types． There was no apparent relation－
ship between the grading of the tumors and the ages of the patients．
  4） Five－year survival
  Of the 56 patients periodically checked， the survival rate of 5 years was 71．6 per cent． Among
the patients with TUEC or TUR treatment， the 5－year survival was 84．6 per cent， while the 5－year
survival among patients with partial cystectomy was 75．8 per cent． The 5．一year survival among
paticnts with surgical therapy in association with chemotherapy and among patients with surgery
and radiotherapy was similar （75．0％ and 71．4％， respectiveiy）， though with the recurrence of tumors，
radiotherapy associated with surgery proved more effective than chemotherapy alone．


























































































Table 2． Age and sex distribution
MoieF’emGleTo十〇［
10～ 1 0 1  0．4％
2Q～ 1 2 3  ｛．3
30～ 8 2 10  4．2
40～ 17 6 23  9．6
50～ 44 8 52 2哩．7
60～ 61 18 79 52．9
70～ 49 ！o 59 24．6

























































































































Table 4． Location of tumors
Areo lnvolvedSinqleMuけipleToセGl
・・・・・・・…｛巳： ・・｛葦§ 66｛き竃 ・28｛亨塁・9・％
Trigone 45 40 85 26，0
Pos†erior woll 48 51 79 24．2
Blqdder neck 2 15 17 5，2
VOUけ 3 11 14 4．3
















































































































































































Table 7． Cellular types and grade of tumors
Ce1剛。r暫ypes Number％
T onsi†ionol cell corcinomo
@       Grode I
@             皿
@             皿















Table 8． Relation between ．chief complaints and cellular type
   Cellulo「












Hemo↑urio弓7o4｝65 4010 4 3 1 61 是99U8．9％
Micfion PQin1 10 6 O O 1 o 10 28X．7％
Poiiokisurio3 3 42 O 1 O 9 22V6％
DysuriG6 6 5 1 O ○ O 8 26X．o％
MiscellGne◎us














はGrade I l7例（ll．3％）， Grade II 74例（49．3％），
Grade III 47例（31．1％）， Grade IV 13例（8．6％〉と
Grade IIおよび皿が多く諸家の報告と一致した．
 また，Francis28）はGrade I 26％， Grade II 36．3































Table 9． Relation between加［mor size and grade
Grgde
1 江 皿 π
Tiny O 8 1 Q
SmoU9 42 18 8
Medlum1 8 14 O
LQrge1 5 6 3











Table 10． Relation between gross appearance
     and grade











































Table 11． Relation between age and grade
Gro  Aqe20～30～40～50～60～70～80～
1 1 3 1 6 6
1［ 1 2 9 15 25 193
Low qrode















皿 3 5 14 20 6 1
π 1 i 6 2 5
High qrode









































































































































  Died of extension
EIS Died of other causes
EI lilY Died of uncertain causes






















































一 Died of extension
∈i≡ヨ Died of other cσuses
四三＝】 Died of uncertain cGuses



































に三部｝C MMC 4 mgを散布し，術後経過をみながら









































M Died ot extension
Ellli：1 Diect of other cou＄es
rw Died of uncertain ceuses
 Fig． 4． 2 year follow up． Chemotherapy














一 Died of extension
口蓋ヨ Died of other couses
圏 Died of uncertain cGuses
 Fig． 5． 5 year follow up． Chemotherapy



















































 至  ＝毒忌 ξち
3〔と   …；〔D
一 Died of extension
ge Died of other couses
EIEEil Died of uncertain causes






































別分類ではGradc Iは17例11・3％， Grade IIは74
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